1. Home
  2. SVRA vs ENVX Comparison

SVRA vs ENVX Comparison

Compare SVRA & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SVRA

Savara Inc.

HOLD

Current Price

$5.30

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$4.89

Market Cap

1.3B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVRA
ENVX
Founded
2007
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
SVRA
ENVX
Price
$5.30
$4.89
Analyst Decision
Buy
Buy
Analyst Count
9
8
Target Price
$7.33
$14.56
AVG Volume (30 Days)
1.4M
5.5M
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.94
EPS
N/A
N/A
Revenue
N/A
$31,821,000.00
Revenue This Year
N/A
$40.85
Revenue Next Year
N/A
$236.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
37.91
52 Week Low
$1.89
$4.84
52 Week High
$7.01
$16.49

Technical Indicators

Market Signals
Indicator
SVRA
ENVX
Relative Strength Index (RSI) 40.47 30.07
Support Level $5.10 N/A
Resistance Level $6.06 $8.73
Average True Range (ATR) 0.31 0.37
MACD -0.03 -0.05
Stochastic Oscillator 6.42 0.94

Price Performance

Historical Comparison
SVRA
ENVX

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

Share on Social Networks: